Long-term study of inherited porphyria conditions
Part of Digestive system, Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This study follows people with diagnosed porphyria over time to learn more about the condition using past and new lab (biochemical) and genetic (DNA) test results. It may help researchers better understand how porphyrias work and support future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of porphyria based on lab test results
- Your diagnosis is also supported by a DNA test finding a porphyria gene mutation
- You (or your parent/guardian) can agree to participate by signing consent/assent forms
- You may be able to join even if you don’t have symptoms, if tests confirm porphyria
- Your porphyria result must not be caused by another illness (secondary porphyrins from liver or bone marrow disease, etc.)
- Your prior diagnosis must be provable from records or by repeating lab or DNA testing if needed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry (a list) of people diagnosed with acute hepatic porphyria. It helps researchers learn about the condition and track health information over time; it doesn’t test a new drug in the way treatment trials do.
This study looks at how genes may affect acute intermittent porphyria (AIP) in families. You may be asked to share health information and provide urine, blood, or saliva samples to help researchers understand what changes genes can make.
This study tracks how your body reacts to sunlight if you have erythropoietic protoporphyria (EPP) or X-linked protoporphyria (XLP)—rare genetic conditions that cause painful skin reactions to sun exposure. Researchers will use special devices and daily logs to better understand your symptoms and how light affects your skin.
This study aims to learn more about rare disorders of purine and pyrimidine metabolism (DPPM), which can affect the brain, immune system, kidneys, and muscles. Researchers will study people with these disorders, their family members, and healthy volunteers to better understand the condition over time.
This study follows people with propionic acidemia to better understand how the body, diet, gut bacteria, and blood chemistry change over time. It may help researchers learn more about the condition and how pregnancy, transplant, and daily life affect health.
This study follows people of all ages with a confirmed POLG-related disease to learn how the condition changes over time. The information collected may help design better care and future treatments.
Hear when a new Acute Porphyrias trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.